Whilst outsourcing of drug development and manufacturing is an attempt to undertake purposeful action in a web of interdependent contingencies, this interview with Ali Pashazadeh, Treehill Partners CEO, by Outsourced Pharma chief editor Louis Garguilo focuses on pathways for the future evolution of the outsourcing ecosystem. Read the full interview:
https://www.outsourcedpharma.com/doc/tariffs-on-toys-and-api-biopharma-as-the-next-battleground-0001